2017
DOI: 10.1016/j.amjcard.2017.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Usefulness of Serial Measurements of Inferior Vena Cava Diameter by Vscan TM to Identify Patients With Heart Failure at High Risk of Hospitalization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
31
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 45 publications
(32 citation statements)
references
References 29 publications
1
31
0
Order By: Relevance
“…The prognostic power of IVC ultrasonography for HF hospitalization has been shown by other authors, [31][32][33][34][35] but only 1 of these studies compared the utility of the IVC measurement with NT-proBNP. 33 In this study, Pellicori et al analyzed the use of IVC ultrasound for a combined variable of cardiovascular mortality and HF hospitalization.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…The prognostic power of IVC ultrasonography for HF hospitalization has been shown by other authors, [31][32][33][34][35] but only 1 of these studies compared the utility of the IVC measurement with NT-proBNP. 33 In this study, Pellicori et al analyzed the use of IVC ultrasound for a combined variable of cardiovascular mortality and HF hospitalization.…”
Section: Discussionmentioning
confidence: 98%
“…Given the difficulty of knowing the volemia status of patients with chronic HF, IVC ultrasound could be a powerful tool to optimize treatment and prevent hospitalization and death. Khandwalla et al found a strong relationship between IVC diameter and the risk of hospitalization for ADHF in patients with chronic HF . However, they did not evaluate the predictive utility of IVC ultrasonography for mortality, or compare it with natriuretic peptides.…”
Section: Introductionmentioning
confidence: 99%
“…[50-53]; detection of complications after biopsy and treatment procedures [54][55][56][57][58]; diffuse liver disease (liver cirrhosis and fatty liver, defined by the detection of focal fatty sparing) [49,59]; 2) biliary system: detection of gall bladder stones, sludge or neoplasia; measurement of bile duct diameter (normal: <6 mm, after cholecystectomy <10 mm) [60]; cholecystitis; 3) pancreas: detection of focal lesions; diffuse parenchymal disorders with pancreatic duct pathology; 3) spleen: splenomegaly (size); lesion detection; lesion characterization; 4) kidney: detection of hydronephrosis; lesion detection including typical cyst; nephrolithiasis >5 mm; 5) aorta and inferior vena cava: abdominal aortic aneurysm [15,18,23,37,[61][62][63][64]; inferior vena cava evaluation [28,36,64]; 6) peritoneal cavity: detection of ascites [4,17,23,35]; guiding abdominal paracentesis [57,58,65,66].…”
Section: Data Acquisition and Analysismentioning
confidence: 99%
“…7 DCIIVC is used for the real-time monitoring of uid removal during continuous renal replacement therapy and uid therapy for heart failure. 4,8,9,10 The qualitative assessment of DCIIVC has also been carried out in a prospective study and demonstrated that DCIIVC offers a rapid, non-invasive way to evaluate VS in critically ill patients. 11 Despite its accuracy and usefulness, DCIIVC is not widely used as a clinical indicator for FR.…”
Section: Discussionmentioning
confidence: 99%
“…DCIIVC is well known as a tool of point-of-care for restrictive uid therapy for heart failure or uid removal for hemodialysis. 4,5 We aimed to evaluate the clinical usefulness of DCIIVC as a tool of point-of-care for uid resuscitation (FR) in critically ill hypotensive patients.…”
Section: Introductionmentioning
confidence: 99%